Haemonetics (HAE) Reports Q4 2026 Earnings Results and Insights
Published on 5/8/2026
AI Summary
Summarized by AI from the source belowHaemonetics (HAE) announced its Q4 2026 earnings, reporting a revenue increase of 10% year-over-year to $250 million. The company highlighted a net income of $30 million, translating to a P/E ratio of 20. This growth indicates strong demand in the healthcare sector. Analysts see potential for continued growth in the coming quarters as healthcare services expand.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
